Resiniferatoxin reduces ventricular arrhythmias in heart failure via selectively blunting cardiac sympathetic afferent projection into spinal cord in rats.
In conclusion, these results firstly demonstrate that central chemo-ablation of the TRPV1+ afferents in spinal cord prevent heart from ventricular arrhythmias in heart failure via selectively blunting cardiac sympathetic afferent projection into spinal cord, which suggest a novel promising therapeutic method for anti-arrhythmia in heart failure.
PMID: 31811858 [PubMed - as supplied by publisher]
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Wu Y, Hu Z, Wang D, Lv K, Hu N Tags: Eur J Pharmacol Source Type: research
More News: Arrhythmia | Calcium | Cardiology | Drugs & Pharmacology | Genetics | Heart | Heart Failure | Reflex Sympathetic Dystrophy | Science | Study